{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:34:30Z","timestamp":1792791270953,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T00:00:00Z","timestamp":1773446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"vor","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"NIH","award":["T32 CA 009599, P30 CA016672"],"award-info":[{"award-number":["T32 CA 009599, P30 CA016672"]}]},{"name":"NIH","award":["R01CA284102"],"award-info":[{"award-number":["R01CA284102"]}]},{"DOI":"10.13039\/100009634","name":"Susan G Komen","doi-asserted-by":"crossref","award":["GTDR17498270"],"award-info":[{"award-number":["GTDR17498270"]}],"id":[{"id":"10.13039\/100009634","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The University of Texas MD Anderson Cancer Center Duncan Family Institute for Cancer Prevention and Risk Assessment through the Center for Community-Engaged Translational Research","id":[{"id":"https:\/\/ror.org\/04twxam07","id-type":"ROR","asserted-by":"crossref"}]},{"name":"The MD Anderson Boot Walk to End Cancer fund; The State of Texas Rare and Aggressive Breast Cancer Grant"},{"name":"The IBC Network"},{"name":"NCI","award":["the Research and Animal Support Facility of the Cancer Center Support (Core) Grant P30 CA016672"],"award-info":[{"award-number":["the Research and Animal Support Facility of the Cancer Center Support (Core) Grant P30 CA016672"]}]},{"name":"Cathy Rain Smith IBC Seed Fund"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-43437-4","type":"journal-article","created":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T11:54:19Z","timestamp":1773489259000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["CCR7 immune cell receptor expression in inflammatory breast cancer"],"prefix":"10.1038","volume":"16","author":[{"given":"Jennifer H.","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wintana","family":"Balema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savitri","family":"Krishnamurthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison N.","family":"Lawrence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie W.","family":"Fowlkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Larson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surbhi","family":"Shivhare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caren","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan M.","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jangsoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilly S.","family":"Villodre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bisrat G.","family":"Debeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto T.","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Van Laere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francois","family":"Bertucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyunwoo","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik P.","family":"Sulman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bora","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy A.","family":"Woodward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,14]]},"reference":[{"issue":"4","key":"43437_CR1","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.suc.2018.03.009","volume":"98","author":"A Menta","year":"2018","unstructured":"Menta, A. et al. Inflammatory Breast Cancer: What to Know About This Unique, Aggressive Breast Cancer. Surg. Clin. North. Am. 98 (4), 787\u2013800. https:\/\/doi.org\/10.1016\/j.suc.2018.03.009 (2018).","journal-title":"Surg. Clin. North. Am."},{"key":"43437_CR2","doi-asserted-by":"publisher","unstructured":"Johnson, K. C. C. et al. Survival outcomes seen with neoadjuvant chemotherapy in the management of locally advanced inflammatory breast cancer (IBC) versus matched controls. Breast 72 https:\/\/doi.org\/10.1016\/j.breast.2023.103591 (2023).","DOI":"10.1016\/j.breast.2023.103591"},{"issue":"4","key":"43437_CR3","doi-asserted-by":"publisher","first-page":"e228","DOI":"10.1016\/S1470-2045(17)30192-4","volume":"18","author":"TM Fouad","year":"2017","unstructured":"Fouad, T. M. et al. Inflammatory breast cancer: a proposed conceptual shift in the AJCC TNM staging system. Lancet Oncol. 18 (4), e228\u2013e232. https:\/\/doi.org\/10.1016\/S1470-2045(17)30192-4 (2017).","journal-title":"Lancet Oncol."},{"issue":"23","key":"43437_CR4","doi-asserted-by":"publisher","first-page":"7965","DOI":"10.1158\/1078-0432.CCR-04-0063","volume":"10","author":"I Van der Auwera","year":"2004","unstructured":"Van der Auwera, I. et al. Increased Angiogenesis and Lymphangiogenesis in Inflammatory versus Noninflammatory Breast Cancer by Real-Time Reverse Transcriptase-PCR Gene Expression Quantification. Clin. Cancer Res. 10 (23), 7965\u20137971. https:\/\/doi.org\/10.1158\/1078-0432.CCR-04-0063 (2004).","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"43437_CR5","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1038\/sj.bjc.6600807","volume":"88","author":"CG Colpaert","year":"2003","unstructured":"Colpaert, C. G. et al. Inflammatory breast cancer shows angiogenesis with high endothelial proliferation rate and strong E-cadherin expression. Br. J. Cancer. 88 (5), 718\u2013725. https:\/\/doi.org\/10.1038\/sj.bjc.6600807 (2003).","journal-title":"Br. J. Cancer"},{"issue":"12","key":"43437_CR6","first-page":"3857","volume":"8","author":"NJ Mccarthy","year":"2002","unstructured":"Mccarthy, N. J. et al. Microvessel Density, Expression of Estrogen Receptor \u03b1, MIB-1, p53, and c-erbB-2 in Inflammatory Breast Cancer. Clin. Cancer Res. 8 (12), 3857\u20133862 (2002).","journal-title":"Clin. Cancer Res."},{"issue":"7","key":"43437_CR7","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1002\/cncr.22927","volume":"110","author":"M Cristofanilli","year":"2007","unstructured":"Cristofanilli, M. et al. Inflammatory breast cancer (IBC) and patterns of recurrence. Cancer 110 (7), 1436\u20131444. https:\/\/doi.org\/10.1002\/cncr.22927 (2007).","journal-title":"Cancer"},{"issue":"1","key":"43437_CR8","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12943-015-0306-4","volume":"14","author":"E Tutunea-Fatan","year":"2015","unstructured":"Tutunea-Fatan, E., Majumder, M., Xin, X. & Lala, P. K. The role of CCL21\/CCR7 chemokine axis in breast cancer-induced lymphangiogenesis. Mol. Cancer. 14 (1), 35. https:\/\/doi.org\/10.1186\/s12943-015-0306-4 (2015).","journal-title":"Mol. Cancer"},{"issue":"16","key":"43437_CR9","doi-asserted-by":"publisher","first-page":"5686","DOI":"10.1158\/1078-0432.CCR-05-0014","volume":"11","author":"N Cabioglu","year":"2005","unstructured":"Cabioglu, N. et al. CCR7 and CXCR4 as Novel Biomarkers Predicting Axillary Lymph Node Metastasis in T1 Breast Cancer. Clin. Cancer Res. 11 (16), 5686\u20135693. https:\/\/doi.org\/10.1158\/1078-0432.CCR-05-0014 (2005).","journal-title":"Clin. Cancer Res."},{"issue":"6824","key":"43437_CR10","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/35065016","volume":"410","author":"A M\u00fcller","year":"2001","unstructured":"M\u00fcller, A. et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 410 (6824), 50\u201356. https:\/\/doi.org\/10.1038\/35065016 (2001).","journal-title":"Nature"},{"issue":"6","key":"43437_CR11","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1093\/annonc\/mdl053","volume":"17","author":"F Andre","year":"2006","unstructured":"Andre, F. et al. Expression of chemokine receptors predicts the site of metastatic relapse in patients with axillary node positive primary breast cancer. Ann. Oncol. 17 (6), 945\u2013951. https:\/\/doi.org\/10.1093\/annonc\/mdl053 (2006).","journal-title":"Ann. Oncol."},{"issue":"4","key":"43437_CR12","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.3390\/cancers12041036","volume":"12","author":"B Rizeq","year":"2020","unstructured":"Rizeq, B. & Malki, M. I. The Role of CCL21\/CCR7 Chemokine Axis in Breast Cancer Progression. Cancers (Basel). 12 (4), 1036. https:\/\/doi.org\/10.3390\/cancers12041036 (2020).","journal-title":"Cancers (Basel)"},{"issue":"5","key":"43437_CR13","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/nri2297","volume":"8","author":"R F\u00f6rster","year":"2008","unstructured":"F\u00f6rster, R., Davalos-Misslitz, A. C. & Rot, A. CCR7 and its ligands: balancing immunity and tolerance. Nat. Rev. Immunol. 8 (5), 362\u2013371. https:\/\/doi.org\/10.1038\/nri2297 (2008).","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"43437_CR14","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0092-8674(00)80059-8","volume":"99","author":"R F\u00f6rster","year":"1999","unstructured":"F\u00f6rster, R. et al. CCR7 Coordinates the Primary Immune Response by Establishing Functional Microenvironments in Secondary Lymphoid Organs. Cell 99 (1), 23\u201333. https:\/\/doi.org\/10.1016\/S0092-8674(00)80059-8 (1999).","journal-title":"Cell"},{"issue":"9","key":"43437_CR15","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/ni1240","volume":"6","author":"SK Bromley","year":"2005","unstructured":"Bromley, S. K., Thomas, S. Y. & Luster, A. D. Chemokine receptor CCR7 guides T cell exit from peripheral tissues and entry into afferent lymphatics. Nat. Immunol. 6 (9), 895\u2013901. https:\/\/doi.org\/10.1038\/ni1240 (2005).","journal-title":"Nat. Immunol."},{"issue":"5","key":"43437_CR16","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1002\/cam4.1039","volume":"6","author":"B Xu","year":"2017","unstructured":"Xu, B., Zhou, M., Qiu, W., Ye, J. & Feng, Q. CCR7 mediates human breast cancer cell invasion, migration by inducing epithelial\u2013mesenchymal transition and suppressing apoptosis through AKT pathway. Cancer Med. (Malden MA). 6 (5), 1062\u20131071. https:\/\/doi.org\/10.1002\/cam4.1039 (2017).","journal-title":"Cancer Med. (Malden MA)"},{"issue":"9","key":"43437_CR17","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1093\/abbs\/gmy077","volume":"50","author":"J Wu","year":"2018","unstructured":"Wu, J. et al. CC chemokine receptor 7 promotes triple-negative breast cancer growth and metastasis. Acta Biochim. Biophys. Sin (Shanghai). 50 (9), 835\u2013842. https:\/\/doi.org\/10.1093\/abbs\/gmy077 (2018).","journal-title":"Acta Biochim. Biophys. Sin (Shanghai)"},{"issue":"1","key":"43437_CR18","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/onc.2015.66","volume":"35","author":"ST Boyle","year":"2016","unstructured":"Boyle, S. T. et al. The chemokine receptor CCR7 promotes mammary tumorigenesis through amplification of stem-like cells. Oncogene 35 (1), 105\u2013115. https:\/\/doi.org\/10.1038\/onc.2015.66 (2016).","journal-title":"Oncogene"},{"issue":"6","key":"43437_CR19","doi-asserted-by":"publisher","first-page":"783","DOI":"10.3748\/wjg.v10.i6.783","volume":"10","author":"C Yan","year":"2004","unstructured":"Yan, C. et al. Expression of vascular endothelial growth factor C and chemokine receptor CCR7 in gastric carcinoma and their values in predicting lymph node metastasis. World J. gastroenterology: WJG. 10 (6), 783\u2013790. https:\/\/doi.org\/10.3748\/wjg.v10.i6.783 (2004).","journal-title":"World J. gastroenterology: WJG"},{"issue":"10","key":"43437_CR20","first-page":"2937","volume":"62","author":"K Mashino","year":"2002","unstructured":"Mashino, K. et al. Expression of chemokine receptor CCR7 is associated with lymph node metastasis of gastric carcinoma. Cancer Res. (Chicago Ill). 62 (10), 2937\u20132941 (2002).","journal-title":"Cancer Res. (Chicago Ill)"},{"issue":"5","key":"43437_CR21","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1158\/0008-5472.can-03-2968","volume":"64","author":"JUN Wang","year":"2004","unstructured":"Wang, J. U. N. et al. Expression pattern of chemokine receptor 6 (CCR6) and CCR7 in squamous cell carcinoma of the head and neck identifies a novel metastatic phenotype. Cancer Res. (Chicago Ill). 64 (5), 1861\u20131866. https:\/\/doi.org\/10.1158\/0008-5472.can-03-2968 (2004).","journal-title":"Cancer Res. (Chicago Ill)"},{"issue":"2","key":"43437_CR22","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/ijc.11063","volume":"105","author":"I Takanami","year":"2003","unstructured":"Takanami, I. Overexpression of CCR7 mRNA in nonsmall cell lung cancer: Correlation with lymph node metastasis. Int. J. Cancer. 105 (2), 186\u2013189. https:\/\/doi.org\/10.1002\/ijc.11063 (2003).","journal-title":"Int. J. Cancer"},{"issue":"5","key":"43437_CR23","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1158\/1078-0432.CCR-04-1195","volume":"11","author":"CC Schimanski","year":"2005","unstructured":"Schimanski, C. C. et al. Effect of Chemokine Receptors CXCR4 and CCR7 on the Metastatic Behavior of Human Colorectal Cancer. Clin. Cancer Res. 11 (5), 1743\u20131750. https:\/\/doi.org\/10.1158\/1078-0432.CCR-04-1195 (2005).","journal-title":"Clin. Cancer Res."},{"issue":"22","key":"43437_CR24","doi-asserted-by":"publisher","first-page":"35656","DOI":"10.18632\/oncotarget.10290","volume":"8","author":"M Mego","year":"2017","unstructured":"Mego, M. et al. Circulating tumor cells (CTCs) are associated with abnormalities in peripheral blood dendritic cells in patients with inflammatory breast cancer. Oncotarget 8 (22), 35656\u201335668. https:\/\/doi.org\/10.18632\/oncotarget.10290 (2017).","journal-title":"Oncotarget"},{"issue":"6","key":"43437_CR25","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1093\/annonc\/mdm060","volume":"18","author":"N Cabioglu","year":"2007","unstructured":"Cabioglu, N. et al. Expression of growth factor and chemokine receptors: new insights in the biology of inflammatory breast cancer. Ann. Oncol. 18 (6), 1021\u20131029. https:\/\/doi.org\/10.1093\/annonc\/mdm060 (2007).","journal-title":"Ann. Oncol."},{"issue":"1","key":"43437_CR26","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s10911-023-09548-8","volume":"28","author":"W Balema","year":"2023","unstructured":"Balema, W. et al. High-fat diet, but not duration of lactation, increases mammary gland lymphatic vessel function and subsequent growth of inflammatory breast cancer cells. J. Mammary Gland Biol. Neoplasia. 28 (1), 21. https:\/\/doi.org\/10.1007\/s10911-023-09548-8 (2023).","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"issue":"8","key":"43437_CR27","doi-asserted-by":"publisher","first-page":"e12180","DOI":"10.1371\/journal.pone.0012180","volume":"5","author":"AH Klopp","year":"2010","unstructured":"Klopp, A. H. et al. Mesenchymal Stem Cells Promote Mammosphere Formation and Decrease E-Cadherin in Normal and Malignant Breast Cells. PLoS One. 5 (8), e12180. https:\/\/doi.org\/10.1371\/journal.pone.0012180 (2010).","journal-title":"PLoS One"},{"issue":"8","key":"43437_CR28","doi-asserted-by":"publisher","first-page":"djw026","DOI":"10.1093\/jnci\/djw026","volume":"108","author":"BG Debeb","year":"2016","unstructured":"Debeb, B. G. et al. miR-141-Mediated Regulation of Brain Metastasis From Breast Cancer. JNCI: J. Natl. Cancer Inst. 108 (8), djw026. https:\/\/doi.org\/10.1093\/jnci\/djw026 (2016).","journal-title":"JNCI: J. Natl. Cancer Inst."},{"issue":"1","key":"43437_CR29","doi-asserted-by":"publisher","first-page":"6889","DOI":"10.1038\/s41467-021-27108-8","volume":"12","author":"A Rogic","year":"2021","unstructured":"Rogic, A. et al. High endogenous CCL2 expression promotes the aggressive phenotype of human inflammatory breast cancer. Nat. Commun. 12 (1), 6889. https:\/\/doi.org\/10.1038\/s41467-021-27108-8 (2021).","journal-title":"Nat. Commun."},{"issue":"7972","key":"43437_CR30","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41586-023-06252-9","volume":"620","author":"T Kumar","year":"2023","unstructured":"Kumar, T. et al. A spatially resolved single-cell genomic atlas of the adult human breast. Nature 620 (7972), 181\u2013191. https:\/\/doi.org\/10.1038\/s41586-023-06252-9 (2023).","journal-title":"Nature"},{"key":"43437_CR31","unstructured":"CZ CELLxGENE Discover. (accessed 12 August 2024); https:\/\/cellxgene.cziscience.com"},{"key":"43437_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2025.05.061","author":"X Sun","year":"2025","unstructured":"Sun, X. et al. Single-cell and spatial transcriptome profiling identifies cellular heterogeneity and immunosuppressive tumor microenvironment in inflammatory breast cancer. J Adv. Res Published online. https:\/\/doi.org\/10.1016\/j.jare.2025.05.061 (2025).","journal-title":"J Adv. Res Published online"},{"issue":"17","key":"43437_CR33","doi-asserted-by":"publisher","first-page":"4685","DOI":"10.1158\/1078-0432.CCR-12-2549","volume":"19","author":"SJ Van Laere","year":"2013","unstructured":"Van Laere, S. J. et al. Uncovering the Molecular Secrets of Inflammatory Breast Cancer Biology: An Integrated Analysis of Three Distinct Affymetrix Gene Expression Datasets. Clin. Cancer Res. 19 (17), 4685\u20134696. https:\/\/doi.org\/10.1158\/1078-0432.CCR-12-2549 (2013).","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"43437_CR34","doi-asserted-by":"publisher","first-page":"211","DOI":"10.5152\/ejbh.2018.4170","volume":"14","author":"B \u00c7akar","year":"2018","unstructured":"\u00c7akar, B. et al. The impact of subtype distribution in inflammatory breast cancer outcome. Eur. J. Breast Health 14 (4), 211\u2013217. https:\/\/doi.org\/10.5152\/ejbh.2018.4170 (2018).","journal-title":"Eur. J. Breast Health"},{"issue":"7_Supplement","key":"43437_CR35","doi-asserted-by":"publisher","first-page":"CT174","DOI":"10.1158\/1538-7445.AM2024-CT174","volume":"84","author":"P Abrisqueta","year":"2024","unstructured":"Abrisqueta, P. et al. Abstract CT174: A phase 1 study of JBH492, an anti C-C chemokine receptor 7 antibody-drug conjugate (anti-CCR7 ADC), assessing safety and efficacy in lymphoid malignancies. Cancer Res. 84 (7_Supplement), CT174\u2013CT174. https:\/\/doi.org\/10.1158\/1538-7445.AM2024-CT174 (2024).","journal-title":"Cancer Res."},{"issue":"13_Supplement","key":"43437_CR36","doi-asserted-by":"publisher","first-page":"4849","DOI":"10.1158\/1538-7445.AM2019-4849","volume":"79","author":"C Cuesta-Mateos","year":"2019","unstructured":"Cuesta-Mateos, C., Mu\u00f1oz-Calleja, C., Loscertales, J., Terron, F. & Mol, W. Abstract 4849: CAP-100: first-in-class anti-CCR7 antibody for CLL. Cancer Res. 79 (13_Supplement), 4849. https:\/\/doi.org\/10.1158\/1538-7445.AM2019-4849 (2019).","journal-title":"Cancer Res."},{"issue":"1","key":"43437_CR37","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s13046-025-03454-z","volume":"44","author":"J Huang","year":"2025","unstructured":"Huang, J. et al. Single-cell transcriptome analysis reveals the malignant characteristics of tumour cells and the immunosuppressive landscape in HER2-positive inflammatory breast cancer. J. Experimental Clin. Cancer Res. 44 (1), 196. https:\/\/doi.org\/10.1186\/s13046-025-03454-z (2025).","journal-title":"J. Experimental Clin. Cancer Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43437-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43437-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43437-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T23:52:55Z","timestamp":1777247575000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43437-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,14]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["43437"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-43437-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,14]]},"assertion":[{"value":"30 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13513"}}